4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-14-000035
Options or other derivatives
- Chief Scientific Officer disposed of 20,000,002 shares (other)
- Chief Scientific Officer acquired 5,697,710 shares (other)
From the SEC's structured data for this filing
Trades in this filing
NIGALAYE ASHOK G · Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-10-17 | Other disposition : show line 1 in the form Warrants | −20,000,002 | 6,726,999 | I |
| 2014-10-17 | Other acquisition : show line 2 in the form Warrants | +5,697,710 | 10,122,043 | D |
Loading xslF345X03/primary_doc.xml…